Clinical Trial - Trial jRCT2031230081
Access comprehensive clinical trial information for jRCT2031230081 through Pure Global AI's free database. This phase not specified trial is sponsored by ABIVAX S.A. and is currently Recruiting. The study focuses on Ulcerative colitis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2031230081
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2031230081
Untitled Trial
A randomized, double blind, placebo controlled, multicenter phase III study to evaluate the efficacy and safety of ABX464 once daily for induction treatment in subjects with moderately to severely active ulcerative colitis (ABTECT 2 ABX464 Treatment Evaluation for ulcerative Colitis Therapy 2)
Study Focus
Interventional
Sponsor & Location
ABIVAX S.A.
Argentina;Belgium;Bosnia;Brazil;Bulgaria;Canada;Croatia;Czech;France;Germany;Greece;Hungary;India;Ir
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Ulcerative colitis
Other ulcerative colitis
Ulcerative colitis, unspecified
Arthropathy in ulcerative colitis
Juvenile arthritis in ulcerative colitis
Data Source
Japan Registry Clinical Trial
jRCT2031230081
Non-Device Trial